Brenton L. Saunders

2017

In 2017, Brenton L. Saunders earned a total compensation of $32.8M as Chairman, President and Chief Executive Officer at Allergan, a 693% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$249
Non-Equity Incentive Plan$8,752,500
Salary$1,232,822
Stock Awards$22,682,025
Other$160,030
Total$32,827,626

Saunders received $22.7M in stock awards, accounting for 69.09% of the total pay in 2017.

Saunders also received $249 of change in pension value and nonqualified deferred compensation earnings, $8.8M in non-equity incentive plan, $1.2M in salary and $160K in other compensation.

Rankings

In 2017, Brenton L. Saunders' compensation ranked 50th out of 14,017 executives tracked by ExecPay. In other words, Saunders earned more than 99.6% of executives.

ClassificationRankingPercentile
All
50
out of 14,017
100th
Division
Manufacturing
9
out of 5,547
100th
Major group
Chemicals And Allied Products
3
out of 1,968
100th
Industry group
Drugs
3
out of 1,632
100th
Industry
Pharmaceutical Preparations
3
out of 1,256
100th
Source: SEC filing on March 23, 2018.

Saunders' colleagues

We found four more compensation records of executives who worked with Brenton L. Saunders at Allergan in 2017.

2017

William Meury

Allergan

Chief Commercial Officer

2017

C Nicholson

Allergan

Chief R&D Officer

2017

Maria Hilado

Allergan

Chief Financial Officer

2017

Robert Stewart

Allergan

Chief Operating Officer

News

You may also like